Musculoskeletal diseases (degenerative diseases of extremity joints and spine, traumatic injuries) Musculoskeletal diseases
Conditions
Interventions
Participants in the treatment group will receive essential amino acids and zinc (VCRESC Cp10) in addition to the hospital meal starting the day after surgery. The non-intake group will receive the hos
Sponsors
Haruta Yohei
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients receiving surgical treatment for musculoskeletal diseases at our hospital from August 1, 2025 to July 31, 2027
Exclusion criteria
Exclusion criteria: Patients with oral intake difficulties, patients with a history of nutritional malabsorption disorders (ulcerative colitis, Crohn's disease, etc.), patients with postoperative higher brain dysfunction or tetraplegia, patients who required reoperation within 1 week after surgery, patients with a history of allergy to VCRESC Cp10.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Prognostic Nutrition Index (PNI) will be calculated from the total blood lymphocyte count and serum albumin concentration and compared between the groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| The amount of change in blood counts and biochemical tests (including hemoglobin concentration, total lymphocyte count, serum albumin concentration, and total cholesterol level) will be compared between groups between groups. Patient background (including clinical score) and surgical data (operation time, blood loss amounts, etc.) will be compared between groups, divided by the correlation between postoperative food intake and changes in perioperative nutritional status, and the presence of complications (delirium, postoperative infection, deterioration of general condition, conditions requiring reoperation or other treatment) within 3 months after surgery. | — |
Contacts
Public ContactHideki Mizu-uchi
Saiseikai Fukuoka General Hospital
Outcome results
None listed